A Joint Model Based on Deep Learning to Predict Multidrug-resistant Klebsiella Pneumoniae Liver Abscess
ConditionLiver Abscess
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorShengjing Hospital
About this trial
The goal of this observational study is to train a deep learning-based model to predict multidrug-resistant Klebsiella pneumoniae liver abscess and evaluate it on a multi-center database.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients diagnosed as pyogenic liver abscess and was proved by surgery or interventional process.
Patients had accepted abdominal enhance CT scans before surgery or interventional process.
Disqualifiers
Patients diagnosed with other types of liver abscess such as amoeba.
Trial population
Pyogenic liver abscess patients in 14years of a multicenter project.
Trial design
Design model
Case-control
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
550 Participants
are grouped into 2 trial groupsGroup A: Patients with ESBL(-) liver abscess
Group B: Patients with ESBL(+) liver abscess
Trial outcomes
Primary outcomes
1
Result of bacteria culture
The result of bacteria culture of abscess decides which group the patients belong. This result was obtained from bacteria culture tests which were done by department of laboratory medicine.
Time frame
The first time before surgery or interventional process, usually within 1 week, up to 4 weeks.2
Result of drug resistant test
Our destination is to find out the potential differences between Esbl(+) \& Esbl(-) liver abscess.
Time frame
The first time before surgery or interventional process, usually within 1 week, up to 4 weeks.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Shengjing Hospital
Lead sponsor
The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial)
Collaborator
Guilin Medical University, China
Collaborator
Hebei General Hospital
Collaborator
Xijing Hospital
Collaborator
Hebei Medical University Third Hospital
Collaborator
The First Affiliated Hospital of Dalian Medical University
Collaborator
The People's Hospital of Liaoning Province
Collaborator
Fourth People's Hospital of Shenyang
Collaborator
Sir Run Run Shaw Hospital
Collaborator
Source ClinicalTrials.gov